Skip to Content

EHA 2019: Venetoclax in combination with Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma

Get access

If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top